Sotera Health Company (SHC)
NASDAQ: SHC · IEX Real-Time Price · USD
13.09
-0.15 (-1.13%)
At close: Jul 19, 2024, 4:00 PM
13.18
+0.09 (0.69%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Sotera Health Company Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for SHC stock have an average target of 16.92, with a low estimate of 13 and a high estimate of 23. The average target predicts an increase of 29.26% from the current stock price of 13.09.
Analyst Consensus: Buy
* Price targets were last updated on May 21, 2024.
Analyst Ratings
The average analyst rating for SHC stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 6 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Initiates $13 | Hold | Initiates | $13 | -0.69% | May 21, 2024 |
| Barclays | Barclays | Buy Maintains $19 → $14 | Buy | Maintains | $19 → $14 | +6.95% | Apr 10, 2024 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $18 → $16 | Hold → Strong Buy | Upgrades | $18 → $16 | +22.23% | Apr 3, 2024 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $15 → $16 | Hold → Strong Buy | Upgrades | $15 → $16 | +18.41% | Mar 25, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $20 | Buy | Reiterates | $20 | +52.79% | Mar 11, 2024 |
Financial Forecast
Revenue This Year
1.11B
from 1.05B
Increased by 6.17%
Revenue Next Year
1.19B
from 1.11B
Increased by 6.91%
EPS This Year
0.72
from 0.18
Increased by 301.83%
EPS Next Year
0.85
from 0.72
Increased by 17.30%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.2B | 1.3B | 1.3B | 1.4B | 1.5B |
| Avg | 1.1B | 1.2B | 1.3B | 1.4B | 1.4B |
| Low | 1.1B | 1.1B | 1.2B | 1.3B | 1.4B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 10.6% | 12.2% | 12.3% | 10.0% | 11.2% |
| Avg | 6.2% | 6.9% | 7.4% | 5.8% | 7.0% |
| Low | 2.8% | 3.0% | 3.5% | 2.7% | 3.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.76 | 0.99 | 1.12 |
| Avg | 0.72 | 0.85 | 1.01 |
| Low | 0.69 | 0.79 | 0.93 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 321.8% | 36.5% | 32.4% |
| Avg | 301.8% | 17.3% | 18.9% |
| Low | 284.4% | 9.7% | 9.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.